The Goldman Sachs Group lowered shares of Oak Street Health (NYSE:OSH – Get Rating) from a buy rating to a neutral rating in a report released on Monday morning, Marketbeat.com reports. They currently have $29.00 target price on the stock, down from their prior target price of $32.00.

Several other equities analysts have also issued reports on the company. Argus started coverage on Oak Street Health in a research note on Tuesday, July 26th. They issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on Oak Street Health in a research note on Thursday, May 26th. They issued an outperform rating and a $26.00 price objective on the stock. Bank of America downgraded Oak Street Health from a buy rating to an underperform rating and dropped their target price for the stock from $26.00 to $18.00 in a research report on Wednesday, June 15th. SVB Leerink increased their target price on Oak Street Health from $23.00 to $32.00 and gave the stock a market perform rating in a research report on Thursday, August 4th. Finally, Barclays increased their target price on Oak Street Health from $31.00 to $34.00 and gave the stock an overweight rating in a research report on Monday, August 8th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of Hold and an average target price of $32.75.

Oak Street Health Stock Performance

OSH stock opened at $28.13 on Monday. The firm has a market cap of $6.79 billion, a PE ratio of -12.88 and a beta of 3.01. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 16.10. The business has a 50 day moving average of $26.40 and a 200-day moving average of $22.56. Oak Street Health has a 12-month low of $13.29 and a 12-month high of $54.14.

Insider Transactions at Oak Street Health

In related news, insider Griffin Myers sold 50,000 shares of the company's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $27.39, for a total transaction of $1,369,500.00. Following the transaction, the insider now directly owns 4,904,159 shares in the company, valued at approximately $134,324,915.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Griffin Myers sold 50,000 shares of the company's stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $27.39, for a total value of $1,369,500.00. Following the completion of the sale, the insider now owns 4,904,159 shares of the company's stock, valued at approximately $134,324,915.01. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Newlight Partners Lp sold 7,000,000 shares of the company's stock in a transaction that occurred on Friday, August 19th. The stock was sold at an average price of $24.72, for a total transaction of $173,040,000.00. Following the completion of the sale, the director now directly owns 33,509,640 shares of the company's stock, valued at approximately $828,358,300.80. The disclosure for this sale can be found here. Insiders have sold a total of 8,248,523 shares of company stock worth $206,854,025 in the last three months. Insiders own 11.40% of the company's stock.

Institutional Investors Weigh In On Oak Street Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of America Corp DE raised its holdings in shares of Oak Street Health by 46.0% in the fourth quarter. Bank of America Corp DE now owns 388,926 shares of the company's stock worth $12,890,000 after buying an additional 122,456 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Oak Street Health by 319.4% in the fourth quarter. Principal Financial Group Inc. now owns 41,651 shares of the company's stock worth $1,381,000 after acquiring an additional 31,719 shares during the period. Teacher Retirement System of Texas increased its stake in shares of Oak Street Health by 18.7% in the fourth quarter. Teacher Retirement System of Texas now owns 18,399 shares of the company's stock worth $610,000 after acquiring an additional 2,894 shares during the period. Confluence Wealth Services Inc. acquired a new stake in Oak Street Health during the fourth quarter valued at $34,000. Finally, Rhumbline Advisers grew its position in Oak Street Health by 1.4% during the fourth quarter. Rhumbline Advisers now owns 92,739 shares of the company's stock valued at $3,073,000 after buying an additional 1,287 shares during the period. Hedge funds and other institutional investors own 91.33% of the company's stock.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

• Get a free copy of the StockNews.com research report on Oak Street Health (OSH)
• Do These Dividend Achievers Deserve A Place In Your Portfolio?
• Darden Restaurants Takes the Low Road Against Inflation
• Why These 3 Stocks Are Off to Hot September Starts
• Inflation Doesn't Differentiate, But it's Impact Does
• 3 Downgraded Must-Have Stocks To Put On Your Watchlist

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.